Space, the final frontier for…med ed?

Share this article:
A healthcare media company working with XM Satellite Radio has launched a 24/7 channel aimed at helping healthcare providers stay current with medical advances. ReachMD’s short-form programming, beamed via satellite signal XM 233, was launched at the American College of Cardiology’s annual meeting in New Orleans last March.

“All the stars are aligned,” joked Mike Seinfeld, ReachMD chief executive.

Programming, hosted by MD- and PhD-level clinicians/researchers, includes clinicians’ roundtable discussion, breaking medical news and special shows. ReachMD plans to offer CME credits via a voice-activated cell phone system starting next month, Seinfeld told MM&M.

Satellite broadcasting is the latest frontier among a burgeoning array of platforms for educating physicians.

ReachMD says it fills a new niche. “[Physicians] needed a national platform to discuss clinical issues that they deal with every day,” said Sharon Griff, ReachMD VP of marketing.

A partnership allows  ReachMD to cull highlights from AMA publication AM News weekly. An editorial board of content advisors, medical producers and reviewers scours medical journals and other sources for topics. Current sponsors include Amgen.

ReachMD was started by obstetrician David Preskill, who didn’t have time to keep up with medical news. Griff cited another reason for the always-on physician news channel: the increasingly informed patient.

“It would be nice for physicians to be as up-to-date or more than the patients they are treating,” she said.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...